Curious about where hemp-derived CBD stands in 2025? Industry experts have broken down the latest science, shifting legal frameworks, and what consumers need to know in a rapidly shifting landscape.
While American culture still broadly either demonizes CBD, or glorifies it, well-researched, accurate, and accessible information that demystifies it and improves literacy surrounding it does exist.
So if you want to know more about the state of hemp-derived CBD legality, research, and use in the United States in 2025, keep reading.
The answer to the question of whether hemp-derived CBD is currently legal in the United States is actually rather complicated, as the regulatory landscape is still in evolution as of this year.
While CBD products with under 0.3% THC on a dry weight basis are now federally legal under the 2018 Farm Bill, the FDA has not yet established comprehensive regulations for its use in food, beverages, or supplements, leaving states to implement their own policies. This has resulted in a fragmented legal environment where CBD’s availability and permitted uses vary widely by location.
This means end-point consumers must do their due diligence before purchasing and consuming any CBD products.
While CBD was once an illegal recreational drug, today, significant scientific research is continuing to explore CBD’s therapeutic potential and safety profile following promising early uptake amongst chronic pain sufferers and cancer patients undergoing chemotherapy.
There are several current inquiries into the impacts of CBD on neurological conditions and behavioral disorders, including PTSD, autism spectrum disorder, and addiction disorders. More diverse studies—including one by the University of California—are also considering its benefits for patients with debilitating illnesses like AIDs.
To date, the body of scientific work on CBD also suggests that it is generally well tolerated, though more long-term studies are needed to confirm its efficacy for these various health conditions.
Because of this promising research, there is growing interest in standardizing product quality and dosage to better protect consumers, and a slate of continued clinical trials has been scheduled with a view to supporting responsible public health decisions.
However, the exact future of CBD in America remains in a state of constant flux.
As a spokesperson for HALF BAK’D—a company committed to improving the American public’s understanding of CBD—said, offering advice for endpoint consumers in this moment of ongoing development, “Always choose CBD that comes with lab results, clean labeling, and clear sourcing. Talk to a doctor before using it, especially if you’re on other medication or managing a health issue."
They added, "Rules around CBD change often, so double-check what’s allowed in your area. And be wary of miracle claims; stick to brands that follow science and stay transparent.”
______________________________________________________
FDA Disclaimer: These statements have not been evaluated by the FDA. This advice is not intended to diagnose, treat, cure, or prevent any disease.
______________________________________________________
